Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
21229 | 368 | 49.4 | 95% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
313 | 17635 | X LINKED AGAMMAGLOBULINEMIA//BRUTONS TYROSINE KINASE//BTK |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VAV | Author keyword | 36 | 45% | 17% | 61 |
2 | VAV1 | Author keyword | 29 | 67% | 7% | 26 |
3 | VAV3 | Author keyword | 5 | 55% | 2% | 6 |
4 | GDP GTP EXCHANGE FACTORS | Author keyword | 4 | 75% | 1% | 3 |
5 | VAV PROTO ONCOGENE | Author keyword | 3 | 100% | 1% | 3 |
6 | HUBERT H HUMPHREY EXPT MED CANC | Address | 2 | 16% | 4% | 13 |
7 | UNIT SINGLE MOL IMMUNOIMAGING | Address | 2 | 67% | 1% | 2 |
8 | MOL IMMUNOL PROGRAMME | Address | 1 | 15% | 2% | 9 |
9 | APL DERIVED CELLS | Author keyword | 1 | 100% | 1% | 2 |
10 | CELL BIOLSIGNAL TRANSDUCT UNIT | Address | 1 | 50% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | VAV | 36 | 45% | 17% | 61 | Search VAV | Search VAV |
2 | VAV1 | 29 | 67% | 7% | 26 | Search VAV1 | Search VAV1 |
3 | VAV3 | 5 | 55% | 2% | 6 | Search VAV3 | Search VAV3 |
4 | GDP GTP EXCHANGE FACTORS | 4 | 75% | 1% | 3 | Search GDP+GTP+EXCHANGE+FACTORS | Search GDP+GTP+EXCHANGE+FACTORS |
5 | VAV PROTO ONCOGENE | 3 | 100% | 1% | 3 | Search VAV+PROTO+ONCOGENE | Search VAV+PROTO+ONCOGENE |
6 | APL DERIVED CELLS | 1 | 100% | 1% | 2 | Search APL+DERIVED+CELLS | Search APL+DERIVED+CELLS |
7 | GRB2 ASH | 1 | 50% | 1% | 2 | Search GRB2+ASH | Search GRB2+ASH |
8 | RHO RAC GTPASES | 1 | 50% | 1% | 2 | Search RHO+RAC+GTPASES | Search RHO+RAC+GTPASES |
9 | SLP76 | 1 | 100% | 1% | 2 | Search SLP76 | Search SLP76 |
10 | VAV FAMILY | 1 | 100% | 1% | 2 | Search VAV+FAMILY | Search VAV+FAMILY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXCHANGE FACTOR VAV | 37 | 65% | 10% | 35 |
2 | SIGNAL TRANSDUCER VAV1 | 23 | 86% | 3% | 12 |
3 | PROTOONCOGENE PRODUCT | 17 | 15% | 29% | 105 |
4 | GTP EXCHANGE FACTOR | 12 | 63% | 3% | 12 |
5 | CELL RECEPTOR SIGNALS | 6 | 100% | 1% | 4 |
6 | PROTOONCOGENE PRODUCT VAV | 5 | 63% | 1% | 5 |
7 | RHO FAMILY | 5 | 12% | 10% | 38 |
8 | VAV PROTOONCOGENE PRODUCT | 5 | 18% | 7% | 24 |
9 | DBL HOMOLOGY DOMAIN | 3 | 20% | 4% | 13 |
10 | GDP GTP EXCHANGE | 2 | 13% | 5% | 17 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Vav-family proteins in T-cell signalling | 2005 | 195 | 67 | 75% |
Guanine nucleotide exchange factors for RhoGTPases: Good therapeutic targets for cancer therapy? | 2011 | 48 | 169 | 40% |
VAV proteins as signal integrators for multi-subunit immune-recognition receptors | 2002 | 194 | 108 | 55% |
Regulatory and signaling properties of the Vav family | 2000 | 360 | 165 | 36% |
Rho family GTPases and their regulators in lymphocytes | 2009 | 99 | 118 | 36% |
Vav1: a key signal transducer downstream of the TCR | 2003 | 73 | 89 | 54% |
Vav proteins, masters of the world of cytoskeleton organization | 2004 | 116 | 117 | 34% |
Flesh and blood: The story of Vav1, a gene that signals in hematopoletic cells but can be transforming in human malignancies | 2007 | 17 | 128 | 52% |
Regulation of Vav proteins by intramolecular events | 2002 | 23 | 44 | 61% |
Vav proteins and lymphocyte activation | 2003 | 3 | 27 | 78% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HUBERT H HUMPHREY EXPT MED CANC | 2 | 16% | 3.5% | 13 |
2 | UNIT SINGLE MOL IMMUNOIMAGING | 2 | 67% | 0.5% | 2 |
3 | MOL IMMUNOL PROGRAMME | 1 | 15% | 2.4% | 9 |
4 | CELL BIOLSIGNAL TRANSDUCT UNIT | 1 | 50% | 0.5% | 2 |
5 | LYMPHOCYTE SIGNALING DEV | 1 | 15% | 2.2% | 8 |
6 | SIGNAL TRANSDUCT UNIT | 1 | 19% | 1.4% | 5 |
7 | MICROBIAL FUNCT GENOM | 1 | 25% | 0.8% | 3 |
8 | NEBRASKA MED 986260 | 1 | 25% | 0.8% | 3 |
9 | LYMPHOCYTE ACTIVAT | 1 | 13% | 1.6% | 6 |
10 | BECKMAN MOL GENET MED DEV BIOL | 1 | 50% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000262610 | SLP 76//LINKER FOR ACTIVATION OF T CELLS//SECT LYMPHOCYTE SIGNALING |
2 | 0.0000256673 | TIAM1//RHOB//RHOGDI2 |
3 | 0.0000224246 | SWAP 70//SWITCH ASSOCIATED PROTEIN 70//DEF6 |
4 | 0.0000154740 | SYK//SPLEEN TYROSINE KINASE//R788 |
5 | 0.0000136220 | IMMUNOLOGICAL SYNAPSE//LYMPHOCYTE INTERACT//PROGRAM MOL PATHOGENESIS |
6 | 0.0000112483 | CBL B//CBL//CIN85 |
7 | 0.0000093861 | BCL10//PKC THETA//CARMA3 |
8 | 0.0000083480 | GRB2//SH2 DOMAIN//SH3 DOMAIN |
9 | 0.0000077661 | KBG SYNDROME//AARSKOG SCOTT SYNDROME//FACIOGENITAL DYSPLASIA |
10 | 0.0000069703 | PAK4//PAK1//P21 ACTIVATED KINASE |